Skip to main content
CLVTClarivate PlcSell4.8·$2.01-16.25%
SellModerate Confidence
Investment thesis

Clarivate presents a stark tension between deeply discounted forward multiples and a deteriorating price trend: free cash flow margins are healthy and the earnings beat streak is intact, but a confirmed technical breakdown with a death cross and momentum in negative territory means the fundamental value has yet to find a price floor — patience until the technical picture stabilizes is warranted.

Thesis pillars

  • Extreme Valuation DiscountStable
  • Positive Free Cash Flow GenerationStable
  • Improving Earnings Beat ConsistencyStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Clarivate Plc (CLVT) Stock Analysis

Range Bound setup · Inst Constrain edge

SellVALUE-TRAP 1/5ValueGrowthQualityShortModerate Confidence

Technology · Information Technology Services

Earnings in 0 days (2026-07-29). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Engine safety override at $2.01: Quality below floor (3.6 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10. Specifically: High short interest: 16%; Below-average business quality; Below long-term trend.

Clarivate provides intelligence and workflow software across three segments — Academia & Government, Intellectual Property, and Life Sciences & Healthcare — serving more than 45,000 customers including universities, law firms, and pharmaceutical companies. Approximately 83% of... Read more

$2.01-1.2% A.UpsideScore 4.8/10#40 of 46 Information Technology Services
QualityF-score5 / 9FCF yield30.86%
Stop $2.00Target $2.57(resistance)A.R:R -0.1:1
Analyst target$2.50+24.4%2 analysts
Range unavailable (2 analysts)

Sell if holding. Engine safety override at $2.01: Quality below floor (3.6 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10. Specifically: High short interest: 16%; Below-average business quality; Below long-term trend. Chart setup: RSI 48 mid-range, Bollinger mid-band. Score 4.8/10, moderate confidence.

Passes 5/10 gates (positive momentum, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 0d<=7d. Suitability: speculative.

10-K grounded · weekly refresh

About Clarivate Plc

About Clarivate Plc

Subscription and re-occurring revenues accounted for approximately 83% of Clarivate's total revenues in fiscal 2025, reflecting the company's three-segment structure — Academia & Government, Intellectual Property, and Life Sciences & Healthcare — serving more than 45,000 customers worldwide. Annual renewal rates exceeded 90% in 2025. More than 12,000 employees operated across more than 40 countries as of December 31, 2025, with the A&G segment's research platform reaching 99% of the top 400 universities.

Clarivate earns revenue through three mechanisms: subscription-based licenses under annual recurring contracts, re-occurring patent and trademark renewal services, and transactional engagements including content sales and consulting. The A&G segment connects more than 26,000 academic libraries with research platforms such as Web of Science. The IP segment serves more than 1,600 corporations and law firms with patent and brand management software, employing more than 2,000 IP service professionals; more than 40 patent offices use the Derwent World Patent Index for prior art examination. The LS&H segment works with more than 3,000 life sciences and healthcare customers including pharmaceutical, biotechnology, and medical device companies. Competition comes from established information services companies with substantial financial resources, and the 10-K specifically flags that free or low-cost general-purpose AI tools may reduce demand for subscription content and that start-up companies may enter markets more quickly than in the past.

Show full overview

Government funding risk is explicitly quantified in the 2025 10-K: Clarivate has already seen 'a reduction in government funding in 2025,' and further budget cuts to academic institutions or government agencies could reduce demand for A&G and LS&H products. The company also maintains an office of approximately 500 employees in Israel; the 10-K notes that several countries have suspended relations with Israel and ongoing Middle East hostilities could affect the company's ability to engage customers or collaborate with third parties. In June 2026, the company disclosed via Form 8-K that Maroun Mourad, President Intellectual Property, departed effective June 9, with Simon Webster appointed successor on June 10.

See also: Technology · Information Technology Services

From Clarivate Plc's most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-30

Recent Developments — Clarivate Plc

Generated 2026-07-30T22:23:47Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 2026today· next earnings call

Thesis

Rewards
No bull case signals
Risks
Target reached (-1.2% upside)
Quality below floor (3.6 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)3.2
Mkt Cap$1.5B
EV/EBITDA6.0
Profit Mgn-5.6%
ROE-2.8%
Rev Growth-1.4%
Beta1.39
DividendNone
Rating analysts13

Quality Signals

Piotroski F5/9

Options Flow

P/C1.00neutral
IV241%elevated

Material Events(8-K, last 90d)

  • 2026-06-08Item 5.02MEDIUM
    Maroun Mourad, President Intellectual Property, departed effective June 9, 2026. Simon Webster appointed successor as President Intellectual Property effective June 10, 2026. Separation agreement includes $450,000 pro-rated bonus and 12-month non-compete. Clean handoff.
    SEC filing →
  • 2026-03-26Item 5.02LOW
    Board adopted Amended and Restated Executive Severance Plan effective March 23, 2026, adding CEO as eligible participant and change-in-control good-reason trigger. No executive departure; routine compensatory arrangement update.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers·1 ceiling hit

Revenue shrinking — -1.4% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
2.1
Declining revenue: -1%
Low model confidence on this dimension (33%).

Unprofitable operations — net margin -5.6%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Roa
0.7
Operating Margin
2.0
Rule Of 40
3.0
Current Ratio
3.4
Moat
4.0
Piotroski F
5.6
Fcf Quality
7.9
Gross Margin
9.3
FCF-positive despite GAAP loss (FCF margin 19%, FCF yield 30.9%)No competitive moatRule of 40: 18 (fail)

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.2
Quality Rank
1.4
Value Rank
7.3
GatesA.R:R -0.1=NEGATIVEEARNINGS PROXIMITY 0d<=7dMomentum 5.1<5.5 (soft — BUY_NOW allowed but watch)Death cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 5.1>=4.5Insider activity: OKNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Speculative
RSI
48 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $1.78Resistance $2.62

Price Targets

$2
$3
A.Upside-1.2%
A.R:R-0.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-1.2% upside)
! Quality below floor (3.6 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLVT stock a buy right now?

Sell if holding. Engine safety override at $2.01: Quality below floor (3.6 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10. Specifically: High short interest: 16%; Below-average business quality; Below long-term trend. Chart setup: RSI 48 mid-range, Bollinger mid-band. Prior stop was $2.00. Score 4.8/10, moderate confidence.

What is the CLVT stock price target?

Take-profit target: $2.57 (-1.2% upside). Prior stop was $2.00. Stop-loss: $2.00.

What are the risks of investing in CLVT?

Target reached (-1.2% upside); Quality below floor (3.6 < 4.0).

Is CLVT overvalued or undervalued?

Clarivate Plc trades at a P/E of N/A (forward 3.2). TrendMatrix value score: 9.6/10. Verdict: Sell.

What do analysts say about CLVT?

13 analysts cover CLVT with a consensus score of 2.7/5. Average price target: $3.

What does Clarivate Plc do?Clarivate provides intelligence and workflow software across three segments — Academia & Government, Intellectual...

Clarivate provides intelligence and workflow software across three segments — Academia & Government, Intellectual Property, and Life Sciences & Healthcare — serving more than 45,000 customers including universities, law firms, and pharmaceutical companies. Approximately 83% of 2025 revenues came from subscription and re-occurring arrangements, with annual renewal rates exceeding 90%. The company employs more than 12,000 people in over 40 countries.

Related stocks: IBEX (IBEX Limited) · INOD (Innodata Inc.) · FORTY (Formula Systems (1985) Ltd.) · VRRM (Verra Mobility Corporation) · EXLS (ExlService Holdings, Inc.)
Home Stocks CLVT

Latest news

Latest News

Benzinga1d ago
Benzinga1d ago
Benzinga2d agoEarnings
Benzinga2d agoLeadership Change
Benzinga2d agoEarnings
Benzinga2d agoEarnings
Benzinga17d agoProduct
Benzinga23d agoAnalyst
Benzinga24d agoMerger Acquisition
Benzinga25d agoProduct
Benzinga28d ago
Benzinga46d agoProduct
Benzinga63d agoProduct
Benzinga71d ago
Benzinga73d agoProduct
Benzinga92d ago
Benzinga92d agoEarnings
Benzinga92d agoEarnings
Benzinga93d agoEarnings
Benzinga93d ago
Loading more...